Minapharm Pharmaceuticals S.A.E. (MIPH.CA)

Also known as:  MINAPHARM
Data delayed by 15 minutes
104.00 EGP -0.14-0.134%
As of 20 OCT 2021 12:08 GMT|Egypt SE

MINAPHARM Stock Price & Performance Powered By Knowledge Direct

Recommendation
-
Div Yield
2.463%
P/E (Last 12 Month)
2.994
Upside
-
Target Price (Mean)
-
52Wk
80.3 03 JAN
132.07 04 MAY

Open
106.98 EGP
Previous Close
104.14 EGP
Turnover
206.26K EGP
EPS
34.787 EGP
Volume
1,975
Transactions
25
Market Cap
1.28B EGP
IPO Date
11-Jan-2004
Analyst Recommendation
Sell
Hold
Buy
Analyst Rating
Strong Buy
Buy
Hold
Sell
Strong Sell

About Minapharm Pharmaceuticals S.A.E.

Country of Incorporation
Established In
1986
Primary Sector
Stock Listing
IDStock TypeCurrencyExchangeSymbol
MIPH.CASEOrdinaryEGPEgypt SEMIPH

Contact details

Primary address
Building: Building 6C
Street: El Bardissi Street, 2T Taksim Asmaa Fahmy Street
Floor: 2nd Floor
Country: Egypt
City: Heliopolis
Related links
www.probiogen.de
Region
Cairo
More
All Press Releases
All Health Care News
All Markets News

Ownership

Revenue
Net Income
Profit Margin
Total Assets
Total Liabilities
Debt to Assets
Operating
Investing
Financing

Company information provided by Refinitiv

Refinitiv research team update company information from primary sources (company annual reports, press releases, company websites, corporate briefings, official statements/interviews) and reliable secondary sources (stock markets, reliable third party publications).

Peers

StocksLast Price% Change
ADVANCED PHARMA1.570 EGP-4.268
MEDICAL PACK0.417 EGP-0.477
ALX. PHARMACEUT.153.900 EGP0.306
CLEOPATRA HOSP4.290 EGP0.941
EGYPT INTL PHRM41.810 EGP-0.948
ARAB PHARM61.380 EGP7.552
More

Thursday Outlook: Asian stocks shuffle higher; oil prices mixed   

Thursday Outlook: Asian stocks shuffle higher; oil prices mixed   

Fresh worries rise as Evergrande asset sale fails, default deadline looms

More

Most Viewed Stocks

Stock Screener

More